Olay Super Serum: What the "Collagen Peptide" on the Front Is on the Back, Read in Label Order

Olay Super Serum draws roughly 27,000 US searches a month by its own name (clickstream estimate, October 2026), and its front-of-pack pitch is arithmetic: five actives, "5-in-1". This page reads the list behind that pitch, in the order Olay declares it, from the product page as served on 6 October 2026. It then asks one question of each named active: what published research exists, and does any of it test this combination. It does not judge the serum and makes no claim about how it performs on skin.

The 18 ingredients, as declared

Olay's page lists the ingredients below. The footnote markers are Olay's own and are reproduced as printed; the right-hand column is what the front of the pack calls each starred item.

Eighteen ingredients is a short list for a product claiming five actives. Every named active sits in the top ten, and the list carries a single preservative and a single fragrance entry. The two minerals near the bottom, mica and titanium dioxide, are the usual source of a serum's pearly look rather than a treatment ingredient.

"Collagen Peptide" is a name the list does not use

The front of the pack and the product description say the serum is "infused with" a Collagen Peptide. The ingredient list never uses that phrase. The starred entry it points to is palmitoyl pentapeptide-4, and the page's own footnote calls it only "Peptide".

Palmitoyl pentapeptide-4 is pal-KTTKS: five amino acids (lysine, threonine, threonine, lysine, serine) with palmitic acid attached so it holds better in an oily film. The five-residue sequence is modelled on a fragment of type I procollagen, which is where the "collagen" in the marketing comes from. It is not collagen protein, it is not a hydrolysed collagen of the kind sold in drinks, and the serum declares no collagen of any kind. Our Matrixyl ingredient file traces the molecule, its trade names and its single maker-run controlled trial; the peptides vs collagen page explains why a signalling peptide and a structural protein are different things.

That naming choice matters for one practical reason. A shopper comparing "collagen peptide" products may be comparing a five-residue cosmetic peptide on one shelf with a food-grade collagen hydrolysate, a mixture of much longer collagen fragments, on another. The words are the same. The ingredients are not.

What position 7 can and cannot say

The peptide sits directly below polyacrylate crosspolymer-6, a thickening polymer, and above the vitamin C derivative. US cosmetic rules require ingredients above 1% to be listed in descending order of amount, but let everything at or below 1% be listed in any order (21 CFR 701.3(f)(2)). Olay does not say where that 1% line falls on this list, so position 7 cannot be read as a measure of how much peptide is in the bottle, and the page does not state the peptide's concentration.

What can be said is narrower. In the one published placebo-controlled trial of palmitoyl pentapeptide-4 — run and published by Procter & Gamble, Olay's maker — the peptide was tested at 3 parts per million in a moisturizer: 0.0003% of the formula (Robinson 2005). A peptide used at that order of magnitude can legitimately appear above ingredients present at far higher levels, because below the 1% line the order is the formulator's choice. Our guide to reading a peptide ingredient list sets out the general rule; this serum is a clean example of it.

The five named actives, one at a time

Olay's description names five actives: niacinamide, vitamin C, collagen peptide, vitamin E and AHA. Each has its own literature. The question this page can answer is what PubMed holds for each, by the name the label uses, as searched on 6 October 2026.

Two lines in that table deserve a closer look.

The vitamin C is a derivative with a thin clinical file. 3-O-ethyl ascorbic acid is ascorbic acid with an ethyl group on one oxygen, designed to be more stable in a water-based serum than plain vitamin C, which oxidises quickly. Read title by title, its 26 PubMed records are mostly skin-penetration, formulation and cell-culture papers, plus one dental and one colitis study. None was tagged as a randomized controlled trial. The vitamin C evidence readers usually have in mind — and that our page on peptides and vitamin C reads — mostly concerns other forms.

The combination has no published trial. A PubMed search for niacinamide together with palmitoyl pentapeptide-4 under any of its names (pal-KTTKS, KTTKS, Matrixyl) returned 6 records: two cell or genomics papers, three reviews or mechanism papers, and a 2026 case report on a serum used with a device. The only one tagged as a randomized trial is Procter & Gamble's own 2009 study of other multi-ingredient products (Kaczvinsky 2009). None tests a formula carrying all five of the serum's named actives, and a search for the product name, "super serum", returned nothing. So the "5-in-1" pitch describes the list accurately — five actives are declared — but no published study tests what those five do together, at these levels, in this base.

The claims on the page

Olay's page makes three kinds of claim, and they rest on different things.

• "Clinically tested to beat the #1 Luxury Serum*". The served page does not name the luxury serum, the number of people tested, the length of the test or what "beat" was measured on. The asterisk's explanation was not in the page text as served. Without a published method this cannot be checked, and it is reported here as the brand's statement only.
• Consumer percentages — 89% said skin felt soft and supple, 88% saw instantly smooth skin, 87% saw instantly refreshed skin. These are self-assessments. The page footnotes a further figure as "Results of high responder based on 8wk clinical study", which signals that at least one number describes the participants who responded most strongly rather than the whole group. No published paper describing the study was found.
• "Penetrates deeply for visible results from day one." Visible same-day effects in a serum with dimethicone, glycerin and mica are expected from the base itself — a smoothing film, water binding and light reflection. None of that needs the peptide, and the page does not separate the two.

Our reading of Olay's Regenerist Micro-Sculpting Cream found the same pattern on another Olay product: a maker that has published real peptide research, and a finished product whose own testing is not published.

Points against the pitch, and points for it

For: the list is short and every named active is declared high on it; niacinamide, at position 4, has 831 randomized-trial records in PubMed; the peptide is one with a published, placebo-controlled human trial behind it; Olay prints the full list on the product page where a plain fetch can read it.

Against: "Collagen Peptide" is a marketing name for a molecule that is not collagen; the vitamin C form has no randomized trial under its own name; no concentration is given for any active; the five-way combination has no published test; the headline comparison names neither its comparator nor its method; and the list ends with fragrance, which matters to anyone avoiding it.

What the label settles, and what it does not

It settles that Super Serum declares 18 ingredients, that the "collagen peptide" is palmitoyl pentapeptide-4 at position 7, and that the five named actives all sit in the top ten. It leaves open how much of each is present, whether the combination does more than niacinamide and the base would do alone, and what the luxury-serum comparison actually measured. Those are questions only a published, controlled test of the finished serum could answer, and this page does not claim to answer them.

Sources

• Olay, Super Serum, olay.com product page and its Shopify product record (/products/super-serum.js): ingredient list with footnotes, description, claims and prices ($46.65 / 1 oz; $66.65 / 1.7 oz). Fetched with plain curl and read 2026-10-06; the product title matched.
• Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci 2005;27(3):155-60. PMID 18492182. Procter & Gamble.
• Kaczvinsky JR, Griffiths CE, Schnicker MS, Li J. Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging. J Cosmet Dermatol 2009;8(3):228-33. PMID 19735523. Procter & Gamble.
• US Code of Federal Regulations, 21 CFR 701.3(f)(2): ingredients at 1% or less may be listed in any order after those above 1%.
• PubMed E-utilities searches, 2026-10-06, with quotedphrasesnotfound read on each: niacinamide AND "randomized controlled trial"[pt] (831); "lactic acid"[tiab] AND skin[tiab] AND "randomized controlled trial"[pt] (56); "palmitoyl pentapeptide-4"[tiab] (5); "ethyl ascorbic acid"[tiab] (26) and with the randomized-trial filter (0); niacinamide[tiab] AND (KTTKS[tiab] OR pal-KTTKS[tiab] OR "palmitoyl pentapeptide-4"[tiab] OR matrixyl[tiab]) (6); "super serum"[tiab] (0, phrase not indexed — read as no record, not as a measured absence). Control: retinol AND skin AND "randomized controlled trial"[pt] returned 334, confirming the filter syntax.